Roberto Caricchio MD

Lupus & Related

Professor of Medicine, Chief, Division of Rheumatology

119 Belmont StreetWorcester, MA 01605
Phone+1 508-334-5224
Fax+1 508-334-5654

Dr. Caricchio is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Caricchio's full profile Already have an account?

Education & Training

Temple University HospitalResidency, Internal Medicine, 2008 - 2014
Temple University HospitalFellowship, Rheumatology, 2012 - 2013
University of Cattolica del Sacro CuoreClass of 1993

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2022 - 2027
PA State Medical License 2005 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

JBT-101 in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2017 Dec 21
COMPLETED
PHASE2
Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. Start of enrollment: 2020 Apr 02
Terminated
Phase 2, Phase 3

Publications & Presentations

PubMed

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment o...
Saira Sheikh, Karen H Costenbader, Joan T Merrill, Susan Manzi, Michelle Petri
Arthritis & Rheumatology. 2026-05-22
Cellular therapies for rheumatic disease.
Fotios Koumpouras, Roberto Caricchio
Current Opinion in Rheumatology. 2026-05-01
Neutrophil transcriptomics in SLE reveals intrinsic disease signatures, shared ex vivo adaptation, and transcriptional reset after CAR T-cell therapy.
Ehsan Dehdashtian, Guangnan Hu, Leah Whiteman, Md Tanimul Islam, Stefania Gallucci
Annals of the Rheumatic Diseases. 2026-03-17

Press Mentions

When the Diagnosis Is Thrown for a LupusMarch 18th, 2026
There Are More Than 100 Autoimmune Diseases, and They Mostly Strike Women. Here’s What to KnowNovember 6th, 2025
Lupus Center at UMass Chan Investigates CAR T-cell Therapy for Severe or Unresponsive Lupus NephritisJuly 15th, 2024

Grant Support

SLE Autoantigen Trafficking And Display During ApoptosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008
SLE Autoantigen Trafficking And Display During ApoptosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008
Apoptotic Nucleosomal DNA And Its Relevance In SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2006